Translational research

30P - Prognostic significance of IGF-1 signaling pathway in patients with advanced non-small cell lung cancer

Authors
  • I. Kotsantis (Athens, Greece)
  • P. Economopoulou (Athens, Greece)
  • A. Psyrri (Athens, Greece)
  • E. Maratou (Athens, Greece)
  • D. Pectasides (Athens, Greece)
  • H. Gogas (Athens, Greece)
  • N. Kentepozidis (Athens, Greece)
  • G. Mountzios (Athens, Greece)
  • G. Dimitriadis (Athens, Greece)
  • S. Giannouli (Athens, Greece)
Speakers
  • I. Kotsantis (Athens, Greece)

Previous ePoster
29P - Pretreatment T790M mutation detection by ultrasensitive PCR assay as predictor of efficacy in non-small lung cancer (NSCLC) patients treated with 1st or 2nd generation EGFR tyrosine kinase inhibitors (TKIs)

Next ePosters
31P - Do two lungs form an integrated immune system? Learning from BALF examination in lung cancer
33P - Prognostic value of CD8-positive tumor stroma-infiltrating lymphocytes and PD-L1 positive tumor cells at initial biopsy in patients with locally advanced NSCLC treated with chemoradiotherapy
35P - Clinicopathological characteristics with genetic profiling and prognostic analysis of primary lymphoepithelioma-like carcinoma in Chinese south-eastern population
36P - Can a BALF profile distinguish hot vs cold lung tumors?
38P - Hedgehog pathway activation might mediate pemetrexed resistance in NSCLC cells
41P - Diagnostic accuracy of droplet digital PCR (ddPCR) and amplification refractory mutation system PCR (ARMS-PCR) for detecting EGFR mutation in cell-free DNA of advanced lung cancer: A meta-analysis
44P - Temporal trends in treatment (Tx) and overall survival (OS) among patients (pts) with incident NSCLC in the UK: A real-oncology database analysis from the I-O Optimise initiative
45P - Treatment (Tx) patterns and overall survival (OS) in patients (pts) with stage IIIB–IV NSCLC in Portugal: An IPO-PORTO database analysis from the I-O Optimise initiative
46P - Evolution of overall survival (OS) in patients (pts) with incident NSCLC in Denmark and Sweden: A SCAN-LEAF study analysis from the I-O Optimise initiative
47P - Treatment (Tx) patterns and overall survival (OS) in patients (pts) with NSCLC in Sweden: A SCAN-LEAF study analysis from the I-O Optimise initiative